{"article_title": "XX in Health releases new 'The State of Women in Healthcare' report, a Rock Health initiative", "article_keywords": ["partners", "releases", "rock", "companies", "state", "making", "xx", "health", "ceos", "healthcare", "report", "initiative", "firms", "women"], "article_url": "http://medcitynews.com/2015/03/xx-health-releases-new-state-women-healthcare-report-rock-health-initiative/", "article_text": "Women are unfortunately still largely underrepresented in healthcare leadership roles. In an effort to make progress, the Rock Health\u2019s XX in Health initiative, created nearly four years ago, is continuing to call attention to the current reality of discrimination and consciously promoting diversity.\n\nThis is not just promoting diversity for the moral principle \u2013 women are an extremely valuable asset to a business, and the numbers show it, as the third annual The State of Women in Healthcare report indicates:\n\nHaving a diverse team creates a positive, virtuous cycle. Companies with women CEOs outperform the stock market, and companies with women on their boards outperform male-only boards by 26 percent. Researchers even estimate that transitioning from a single-gender office to an office evenly split between men and women be associated with a revenue gain of 41%. Not only do companies with more women in leadership yield better economic returns, recent research also suggests it helps mitigate risk. One study shows that each additional female director reduces the number of a company\u2019s attempted takeover bids by 7.6%. Another study indicates that companies with more women on their board had fewer instances of governance-related scandals such as bribery, corruption, fraud, and shareholder battles.\n\nThe report doesn\u2019t just highlight why diversity is entirely worthwhile, it also points out the current status of where women stand in the industry.\n\nDespite making up more than half the healthcare workforce, women represent only 21% of executives and 21% of board members at Fortune 500 healthcare companies. Of the 125 women who carry an executive title, only five serve in operating roles as COO or President. And there\u2019s only one woman CEO of a Fortune 500 healthcare company.\n\nAnd, not surprisingly, the same problem crosses over into venture capitalism.\n\nWe know from our funding data that women make up only 6% of digital health CEOs funded in the last four years. When we looked at the gender breakdown of the 148 VC firms investing in digital health, we understood why. Women make up only 10% of partners, those responsible for making final investment decisions. In fact, 75 of those firms have ZERO women partners (including Highland Capital, Third Rock, Sequoia, Shasta Ventures). Venture firms with women investment partners are 3X more likely to invest in companies with women CEOs. It\u2019s no wonder women CEOs aren\u2019t getting funded.\n\nTackling this issue and making improvements is a matter of awareness, and XX in Health is doing just that. It\u2019s a problem that isn\u2019t always a product of intent or conscious discrimination, but it continues to happen in a big way.\n\nThis week Rock Health is hosting a webinar on the topic for both men and women. Next week the sixth XX in Health Retreat in will take place in NYC.", "article_metadata": {"description": "Women are unfortunately still largely underrepresented in healthcare leadership roles. In an effort to make progress, the Rock Health\u2019s XX in Health initiative, created nearly four years ago, is continuing to call attention to the current reality of discrimination and consciously promoting diversity. This is not just promoting diversity for the moral principle \u2013 women are an extremely valuable asset to a business, and the numbers show it, as the third annual The State of Women in Healthcare report indicates: Having a diverse team creates a positive, virtuous cycle. Companies with women CEOs outperform the stock market, and companies with women on their boards outperform male-only boards by 26 percent. Researchers even estimate that transitioning from a single-gender office to an office evenly split between men and women be associated with a revenue gain of 41%. Not only do companies with more women in leadership yield better economic returns, recent research also suggests it helps mitigate risk. One study shows that each additional female director reduces the number of a company\u2019s attempted takeover bids by 7.6%. Another study indicates that companies with more women on their board had fewer instances of governance-related scandals such as bribery, corruption, fraud, and shareholder battles. The report doesn\u2019t just highlight why diversity is entirely worthwhile, it also points out the current status of where women stand in the industry. Despite making up more than half the healthcare workforce, women represent only 21% of executives and 21% of board members at Fortune 500 healthcare companies. Of the 125 women who carry an executive title, only five serve in operating roles as COO or President. And there\u2019s only one woman CEO of a Fortune 500 healthcare company. And, not surprisingly, the same problem crosses over into venture capitalism. We know from our funding data that women make up only 6% of digital health CEOs funded in the last four years. When we looked at the gender breakdown of the 148 VC firms investing in digital health, we understood why. Women make up only 10% of partners, those responsible for making final investment decisions. In fact, 75 of those firms have ZERO women partners (including Highland Capital, Third Rock, Sequoia, Shasta Ventures). Venture firms with women investment partners are 3X more likely to invest in companies with women CEOs. It\u2019s no wonder women CEOs aren\u2019t getting funded. Tackling this issue and making improvements is a matter of awareness, and XX in Health is doing just that. It\u2019s a problem that isn\u2019t always a product of intent or conscious discrimination, but it continues to happen in a big way. This week Rock Health is hosting a webinar on the topic for both men and women. Next week the sixth XX in Health Retreat in will take place in NYC.    The State of Women in Healthcare 2015  from Rock Health", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "Women are unfortunately still largely underrepresented in healthcare leadership roles. In an effort to make progress, the Rock Health\u2019s XX in Health initiative, created nearly four years ago, is continuing to call attention to the current reality of discrimination and consciously promoting diversity. This is not just promoting diversity for the moral principle \u2013 women are an extremely valuable asset to a business, and the numbers show it, as the third annual The State of Women in Healthcare report indicates: Having a diverse team creates a positive, virtuous cycle. Companies with women CEOs outperform the stock market, and companies with women on their boards outperform male-only boards by 26 percent. Researchers even estimate that transitioning from a single-gender office to an office evenly split between men and women be associated with a revenue gain of 41%. Not only do companies with more women in leadership yield better economic returns, recent research also suggests it helps mitigate risk. One study shows that each additional female director reduces the number of a company\u2019s attempted takeover bids by 7.6%. Another study indicates that companies with more women on their board had fewer instances of governance-related scandals such as bribery, corruption, fraud, and shareholder battles. The report doesn\u2019t just highlight why diversity is entirely worthwhile, it also points out the current status of where women stand in the industry. Despite making up more than half the healthcare workforce, women represent only 21% of executives and 21% of board members at Fortune 500 healthcare companies. Of the 125 women who carry an executive title, only five serve in operating roles as COO or President. And there\u2019s only one woman CEO of a Fortune 500 healthcare company. And, not surprisingly, the same problem crosses over into venture capitalism. We know from our funding data that women make up only 6% of digital health CEOs funded in the last four years. When we looked at the gender breakdown of the 148 VC firms investing in digital health, we understood why. Women make up only 10% of partners, those responsible for making final investment decisions. In fact, 75 of those firms have ZERO women partners (including Highland Capital, Third Rock, Sequoia, Shasta Ventures). Venture firms with women investment partners are 3X more likely to invest in companies with women CEOs. It\u2019s no wonder women CEOs aren\u2019t getting funded. Tackling this issue and making improvements is a matter of awareness, and XX in Health is doing just that. It\u2019s a problem that isn\u2019t always a product of intent or conscious discrimination, but it continues to happen in a big way. This week Rock Health is hosting a webinar on the topic for both men and women. Next week the sixth XX in Health Retreat in will take place in NYC.    The State of Women in Healthcare 2015  from Rock Health", "title": "XX in Health releases new \u2018The State of Women in Healthcare\u2019 report, a Rock Health initiative", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/Binders.png", "updated_time": "2015-03-24T08:37:49-04:00", "url": "http://medcitynews.com/2015/03/xx-health-releases-new-state-women-healthcare-report-rock-health-initiative/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/Binders.png", "description": "Women are unfortunately still largely underrepresented in healthcare leadership roles. In an effort to make progress, the Rock Health\u2019s XX in Health initiative, created nearly four years ago, is continuing to call attention to the current reality of discrimination and consciously promoting diversity. This is not just promoting diversity for the moral principle \u2013 women are an extremely valuable asset to a business, and the numbers show it, as the third annual The State of Women in Healthcare report indicates: Having a diverse team creates a positive, virtuous cycle. Companies with women CEOs outperform the stock market, and companies with women on their boards outperform male-only boards by 26 percent. Researchers even estimate that transitioning from a single-gender office to an office evenly split between men and women be associated with a revenue gain of 41%. Not only do companies with more women in leadership yield better economic returns, recent research also suggests it helps mitigate risk. One study shows that each additional female director reduces the number of a company\u2019s attempted takeover bids by 7.6%. Another study indicates that companies with more women on their board had fewer instances of governance-related scandals such as bribery, corruption, fraud, and shareholder battles. The report doesn\u2019t just highlight why diversity is entirely worthwhile, it also points out the current status of where women stand in the industry. Despite making up more than half the healthcare workforce, women represent only 21% of executives and 21% of board members at Fortune 500 healthcare companies. Of the 125 women who carry an executive title, only five serve in operating roles as COO or President. And there\u2019s only one woman CEO of a Fortune 500 healthcare company. And, not surprisingly, the same problem crosses over into venture capitalism. We know from our funding data that women make up only 6% of digital health CEOs funded in the last four years. When we looked at the gender breakdown of the 148 VC firms investing in digital health, we understood why. Women make up only 10% of partners, those responsible for making final investment decisions. In fact, 75 of those firms have ZERO women partners (including Highland Capital, Third Rock, Sequoia, Shasta Ventures). Venture firms with women investment partners are 3X more likely to invest in companies with women CEOs. It\u2019s no wonder women CEOs aren\u2019t getting funded. Tackling this issue and making improvements is a matter of awareness, and XX in Health is doing just that. It\u2019s a problem that isn\u2019t always a product of intent or conscious discrimination, but it continues to happen in a big way. This week Rock Health is hosting a webinar on the topic for both men and women. Next week the sixth XX in Health Retreat in will take place in NYC.    The State of Women in Healthcare 2015  from Rock Health", "card": "summary", "title": "XX in Health releases new 'The State of Women in Healthcare' report, a Rock Health initiative - MedCity News"}, "fb": {"app_id": 148725768475669}, "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,Rock Health, The State of Women in Healthcare, XX in Health, , MedCity News", "article": {"section": "Daily", "tag": "XX in Health", "published_time": "2015-03-23T14:56:40-04:00", "modified_time": "2015-03-24T08:37:49-04:00"}, "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "_id": "\"57477af46914bd0286fdb3a2\"", "article_summary": "Companies with women CEOs outperform the stock market, and companies with women on their boards outperform male-only boards by 26 percent.\nThis week Rock Health is hosting a webinar on the topic for both men and women.\nVenture firms with women investment partners are 3X more likely to invest in companies with women CEOs.\nWe know from our funding data that women make up only 6% of digital health CEOs funded in the last four years.\nDespite making up more than half the healthcare workforce, women represent only 21% of executives and 21% of board members at Fortune 500 healthcare companies."}